Seeing Machines targets positive EBITDA as GSR regulation set to drive royalty surge

Seeing Machines expects adjusted EBITDA to turn positive in Q3 and for the second half of the fiscal year, driven by a significant rise in automotive royalty volumes as the EU General Safety Regulation (GSR) mandates driver monitoring systems. Management says royalties from production volumes will increase materially in coming quarters as OEMs shift compliance into production, improving near-term profitability and revenue visibility from regulatory-driven demand.

Analysis

The regulatory push forces a structural shift from one-off system sales to recurring, per-vehicle royalty economics: that changes the revenue cadence from lumpy OEM contracts to potentially predictable, high-operating-leverage streams as production volumes scale. Expect the P&L inflection to be visible first in gross margin expansion and operating leverage (fixed R&D amortized over more units) rather than top-line linearity — meaning profitability can appear quickly even while absolute revenue remains lumpy. Near-term supply-chain effects are likely concentrated in IR illumination, camera modules and a narrow set of vision SoCs; shortages or qualification delays in any of these components can throttle royalty flow even if OEM intent is unchanged.

Competitive dynamics favor specialists with validated software stacks and certification credentials because OEM homologation cycles penalize rework; that gives incumbents a 6–18 month window of pricing power before integrated SoC players (Mobileye/Qualcomm-tier) can bundle equivalent functionality. Second-order winners include Tier-1s that act as integrators and suppliers of calibrated camera modules and IR subsystems — they will see volume growth but face margin compression versus software royalties. Key reversal risks are OEM insourcing or aggressive bundling by large ADAS platform suppliers, real-world liability events that force functional re-specs, and EU enforcement/interpretation shifts that delay implementation by 3–12 months.

Catalysts to watch on a 0–12 month horizon are: quarterly royalty disclosures and sequential unit growth, first OEM production-by-plant announcements, EU regulatory enforcement guidance clarifying compliance testing, and any large OEM contract that replaces a competitor. The optimal tactical approach is to time exposure to near-term quarterly updates and to protect position size against execution/qualification slips; liquidity on AIM/OTC lines can amplify volatility, so prefer option structures or spreads to outright concentrated equity exposure if operational risk is non-trivial.

Key Decisions for Investors

• Long SEE (AIM:SEE / OTC:SEEMF) — tactical position 2–4% NAV, horizon 3–9 months. Rationale: capture EBITDA re-rating from royalty leverage; target 50–150% upside if sequential unit royalties grow and margin inflection persists. Risk control: hard stop-loss at -30% or hedge with puts sized to 25–50% of the position.
• Buy a 9–15 month call-spread on SEE to play the production ramp while capping downside (long nearer-term ATM call, sell higher OTM longer-dated call). Position size = 50–75% of a direct equity allocation. Reward: asymmetric upside if royalties crystallize; max loss = premium paid.
• Pair-trade: Long SEE (1–2% NAV) / Short Continental AG (FRA:CON) or Aptiv (NYSE:APTV) (1–2% NAV) — horizon 6–12 months. Rationale: specialist royalties re-rate faster than diversified Tier-1 suppliers that will face margin pressure from integration and pricing competition. Rebalance on quarterly OEM disclosures or if OEM-level wins show broad platform adoption.
• Event hedge: buy 3–6 month puts on SEE sized to 25–50% of the equity position ahead of the next quarterly update or major OEM production announcement. Trigger: exercise or add hedges if OEM production slips by >1 quarter or if EU enforcement guidance materially changes.